Bangladesh vs Iraq: Cause of death, by non-communicable diseases, ages 15-59, female
Bangladesh
65.1%
in 2021
Iraq
65.5%
in 2021
Bangladesh rank
79th
Iraq rank
77th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Bangladesh
- Iraq
How they compare
Iraq currently reports 65.5% against 65.1% in Bangladesh, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Iraq ahead.
Bangladesh ranks 79th and Iraq ranks 77th of 185 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Bangladesh | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.2% | 64.7% | 14.5% | Iraq |
| 2010s | 66.7% | 64.2% | 2.5% | Bangladesh |
| 2020s | 66.0% | 62.6% | 3.4% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Bangladesh or Iraq?
- Iraq, at 65.5% against 65.1% in Bangladesh as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Bangladesh and Iraq?
- 0.4%, with Iraq ahead.
- How many years of comparable data are there for Bangladesh and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Bangladesh and Iraq rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Bangladesh ranks 79th and Iraq ranks 77th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.